199 related articles for article (PubMed ID: 12562215)
21. [UDP-glucuronyltransferases in detoxification and activation metabolism of endogenous compounds and xenobiotics].
Fedejko B; Mazerska Z
Postepy Biochem; 2011; 57(1):49-62. PubMed ID: 21735820
[TBL] [Abstract][Full Text] [Related]
22. UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation.
Mori A; Maruo Y; Iwai M; Sato H; Takeuchi Y
Drug Metab Dispos; 2005 May; 33(5):672-5. PubMed ID: 15708967
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation enzymes, genes and psychiatry.
de Leon J
Int J Neuropsychopharmacol; 2003 Mar; 6(1):57-72. PubMed ID: 12899737
[TBL] [Abstract][Full Text] [Related]
24. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases.
Zhou J; Zhang J; Xie W
Curr Drug Metab; 2005 Aug; 6(4):289-98. PubMed ID: 16101569
[TBL] [Abstract][Full Text] [Related]
25. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
Yuan L; Qian S; Xiao Y; Sun H; Zeng S
Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
[TBL] [Abstract][Full Text] [Related]
26. Drug and xenobiotic glucuronidation catalysed by cloned human liver UDP-Glucuronosyltransferases stably expressed in tissue culture cell lines.
Wooster R; Ebner T; Sutherland L; Clarke D; Burchell B
Toxicology; 1993 Oct; 82(1-3):119-29. PubMed ID: 8236271
[TBL] [Abstract][Full Text] [Related]
27. Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.
Fujiwara R; Yokoi T; Nakajima M
Front Pharmacol; 2016; 7():388. PubMed ID: 27822186
[TBL] [Abstract][Full Text] [Related]
28. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
[TBL] [Abstract][Full Text] [Related]
29. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.
Batt AM; Magdalou J; Vincent-Viry M; Ouzzine M; Fournel-Gigleux S; Galteau MM; Siest G
Clin Chim Acta; 1994 May; 226(2):171-90. PubMed ID: 7923812
[TBL] [Abstract][Full Text] [Related]
30. [Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer].
Wang Y; Zheng Y
Wei Sheng Yan Jiu; 2008 Sep; 37(5):629-32. PubMed ID: 19069670
[TBL] [Abstract][Full Text] [Related]
31. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
32. Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.
Yuan LM; Gao ZZ; Sun HY; Qian SN; Xiao YS; Sun LL; Zeng S
Sci Rep; 2016 Nov; 6():34450. PubMed ID: 27857056
[TBL] [Abstract][Full Text] [Related]
33. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
Margaillan G; Rouleau M; Fallon JK; Caron P; Villeneuve L; Turcotte V; Smith PC; Joy MS; Guillemette C
Drug Metab Dispos; 2015 Apr; 43(4):611-9. PubMed ID: 25650382
[TBL] [Abstract][Full Text] [Related]
34. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.
Nagar S; Remmel RP
Oncogene; 2006 Mar; 25(11):1659-72. PubMed ID: 16550166
[TBL] [Abstract][Full Text] [Related]
35. UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
Yang N; Sun R; Liao X; Aa J; Wang G
Pharmacol Res; 2017 Jul; 121():169-183. PubMed ID: 28479371
[TBL] [Abstract][Full Text] [Related]
36. Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
Strassburg CP; Kalthoff S; Ehmer U
Crit Rev Clin Lab Sci; 2008; 45(6):485-530. PubMed ID: 19003600
[TBL] [Abstract][Full Text] [Related]
37. Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Tukey RH; Strassburg CP
Annu Rev Pharmacol Toxicol; 2000; 40():581-616. PubMed ID: 10836148
[TBL] [Abstract][Full Text] [Related]
38. Substrate specificity of human hepatic udp-glucuronosyltransferases.
Burchell B; Lockley DJ; Staines A; Uesawa Y; Coughtrie MW
Methods Enzymol; 2005; 400():46-57. PubMed ID: 16399342
[TBL] [Abstract][Full Text] [Related]
39. The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.
Ouzzine M; Gulberti S; Ramalanjaona N; Magdalou J; Fournel-Gigleux S
Front Cell Neurosci; 2014; 8():349. PubMed ID: 25389387
[TBL] [Abstract][Full Text] [Related]
40. Ontogeny of hepatic glucuronidation; methods and results.
Krekels EH; Danhof M; Tibboel D; Knibbe CA
Curr Drug Metab; 2012 Jul; 13(6):728-43. PubMed ID: 22452455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
